Cart 0

MarketsandMarkets

Biomaterials Market - Global Forecast to 2021

$5,650.00

Report Published By: MarketsandMarkets
Publication Date : Jan-17
No. Of Pages: 264

The biomaterials market is projected to reach 149.17 billion by 2021 million from 70.90 billion in 2016, at a CAGR of 16.0%.

Factors such as increasing funds and grants by governments worldwide, rising incidence of cardiovascular diseases, technological advancements, the growing implantable devices market, globally rising cases of hip and knee replacement procedures, rising awareness of tissue engineering, and high growth in geriatric population are driving the growth of the market. On the other hand, stringent clinical and regulatory processes and unfavorable healthcare reforms in the U.S., is expected to restrain the growth of the market.

The demand for biodegradable polymers has increased, owing to its superior biocompatibility and ability to slowly degrade inside the body, thus eliminating the need for removal. Superior physicochemical & biocompatible properties and the increasing application areas of polymeric materials are likely to boost the growth of the market. However, polymers are costly, which can hinder the growth of this market. A biomaterial is a natural or synthetic material suited to replace or treat natural body tissues and organs on interaction with biological systems.

The plastic surgery segment is expected to grow at the highest CAGR during forecast period, due to growing number of elderly people, positive public perception towards cosmetic surgeries, and technological advances are factors increasing the demand for plastic surgeries. In 2016, the cardiovascular segment is expected to account for the largest share of the market, due to factors such as increasing prevalence of cardiovascular diseases, increasing angiography procedures, and growing usage of cardiac stents that are considered a safe option for coronary angioplasty treatment.

In 2016, North America is expected to account for the largest share of the global biomaterial market, followed by Europe, Asia-Pacific, and RoW. Rising biomaterial-based research, increasing demand for plastic surgeries, increasing conferences on biomaterials, growing cancer incidence, and the rising prevalence of cardiovascular diseases are expected to drive market growth in this region. In the coming years, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to factors such as increasing Japan’s growing healthcare industry, increasing aging population, and high incidence of cardiovascular diseases in India and China.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global biomaterials market.

In-depth interviews were conducted with CEOs, sales and marketing directors, other innovation and technology directors, and executives from various key organizations operating in the biomaterials market.

? By Company Type: Tier 1: 34%, Tier 2: 38%, Tier 3: 28%
? By Designation: Director-level: 31%, C-level: 35%, Others: 34%
? By Region: North America: 28%, Europe: 31%, APAC: 24%, RoW: 17%
The report includes the study of key players

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of top players in the biomaterials market. The report analyzes the biomaterials market, by type of material and application
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the biomaterials market
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various biomaterials across regions
• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the biomaterials market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the biomaterials market

TABLE OF CONTENTS

1 INTRODUCTION 23
1.1 OBJECTIVES OF STUDY 23
1.2 MARKET DEFINITION 23
1.2.1 MARKETS COVERED 24
1.2.2 YEARS CONSIDERED FOR THE STUDY 24
1.3 CURRENCY 25
1.4 LIMITATIONS 25
1.5 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH METHODOLOGY STEPS 26
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 27
2.2.1 SECONDARY RESEARCH 27
2.2.2 PRIMARY RESEARCH 28
2.2.2.1 Key data from primary sources 29
2.2.2.2 Key insights from primary sources 30
2.2.2.3 Key industry insights 31
2.3 MARKET SIZE ESTIMATION METHODOLOGY 31
2.4 RESEARCH DESIGN 33
2.5 MARKET DATA VALIDATION AND TRIANGULATION 34
2.6 ASSUMPTIONS FOR THE STUDY 35
3 EXECUTIVE SUMMARY 36
3.1 INTRODUCTION 36
3.2 CONCLUSION 43
4 PREMIUM INSIGHTS 44
4.1 GLOBAL BIOMATERIALS MARKET OVERVIEW 44
4.2 GLOBAL BIOMATERIALS MARKET, BY APPLICATION 45
4.3 GEOGRAPHIC ANALYSIS: BIOMATERIALS MARKET, BY TYPE 46
4.4 GEOGRAPHIC SNAPSHOT: BIOMATERIALS MARKET 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
5.2.1 DRIVERS 50
5.2.1.1 Increased funds and grants by government bodies for the development of novel biomaterials 50
5.2.1.2 Increasing demand for implantable devices 51
5.2.1.3 Growing demand for biomaterials in plastic surgery and wound healing applications 51
5.2.1.4 Rising number of hip and knee replacement procedures 51
5.2.1.5 Rising geriatric population and the subsequent growth in incidence of cardiovascular diseases 52
5.2.1.6 Increasing awareness about regenerative medicine 52
5.2.2 RESTRAINTS 53
5.2.2.1 Stringent clinical & regulatory processes 53
5.2.2.2 Unfavorable healthcare reforms in the U.S. 53
5.2.3 OPPORTUNITIES 54
5.2.3.1 Growing healthcare market in emerging economies 54
5.2.3.2 Increasing number of free-trade agreements 54
5.2.4 CHALLENGES 55
5.2.4.1 Limitations of biomaterial-based products 55
6 REGULATORY ASSESSMENT 56
6.1 INTRODUCTION 56
6.2 U.S. 56
6.2.1 INTRODUCTION 56
6.2.2 FDA DEVICE CLASSIFICATION 57
6.2.3 U.S.: REGULATORY APPROVAL TIMELINE ASSESSMENT 59
6.2.4 STRINGENT FDA REGULATIONS GOVERNING PRODUCT APPROVALS 60
6.3 EUROPE 60
6.3.1 INTRODUCTION 60
6.3.2 EUROPEAN MEDICAL DEVICE CLASSIFICATION 61
6.3.3 EUROPE: REGULATORY APPROVAL TIMELINE ASSESSMENT 63
6.3.4 EUROPEAN REGULATORY PROCESS TO GET MORE STRINGENT IN FUTURE 63
6.4 JAPAN 64
6.4.1 INTRODUCTION 64
6.4.2 PMDA DEVICE CLASSIFICATION 64
6.4.3 JAPAN: REGULATORY APPROVAL TIMELINE ASSESSMENT 66
6.4.4 REVISION OF THE PHARMACEUTICAL AFFAIRS LAW (PAL) AND IMPLEMENTATION OF THE NEW PMD ACT IN JAPAN 66
6.5 CHINA 67
6.5.1 INTRODUCTION 67
6.5.2 CFDA DEVICE CLASSIFICATION 67
6.5.3 CHINA: REGULATORY APPROVAL TIMELINE ASSESSMENT 69
6.5.4 RISING HURDLES IN THE REGULATORY PROCESS IN CHINA 69
6.6 INDIA 70
6.6.1 INTRODUCTION 70
6.6.2 INDIA: REGULATORY APPROVAL TIMELINE ASSESSMENT 71
?
6.7 AUSTRALIA 72
6.7.1 INTRODUCTION 72
6.7.2 TGA DEVICE CLASSIFICATION 72
6.7.3 AUSTRALIA: REGULATORY APPROVAL TIMELINE ASSESSMENT 74
7 GLOBAL BIOMATERIALS MARKET, BY TYPE OF MATERIAL 75
7.1 INTRODUCTION 76
7.2 METALLIC BIOMATERIALS 77
7.2.1 STAINLESS STEEL 79
7.2.2 TITANIUM & TITANIUM ALLOYS 79
7.2.3 COBALT-CHROME ALLOYS 80
7.2.4 GOLD 81
7.2.5 SILVER 81
7.2.6 MAGNESIUM 82
7.3 CERAMICS 83
7.3.1 CALCIUM PHOSPHATE 84
7.3.2 ZIRCONIA 85
7.3.3 ALUMINUM OXIDE 85
7.3.4 CALCIUM SULFATE 86
7.3.5 CARBON 87
7.3.6 GLASS 87
7.4 POLYMERS 88
7.4.1 POLYMETHYLMETHACRYLATE (PMMA) 90
7.4.2 POLYETHYLENE 90
7.4.3 POLYESTER 91
7.4.4 POLYVINYLCHLORIDE (PVC) 92
7.4.5 SILICONE RUBBER 92
7.4.6 NYLON 93
7.4.7 POLYETHERETHERKETONE (PEEK) 94
7.4.8 POLYLACTIC ACID, POLY GLYCOLIC ACID, AND POLY(LACTIDE-CO-GLYCOLIDE) 94
7.4.9 OTHER POLYMERS 95
7.5 NATURAL BIOMATERIALS 96
7.5.1 HYALURONIC ACID 99
7.5.2 COLLAGEN 99
7.5.3 GELATIN 100
7.5.4 FIBRIN 100
7.5.5 CELLULOSE 101
7.5.6 CHITIN 101
7.5.7 ALGINATES 102
7.5.8 SILK 102
?
8 BIOMATERIALS MARKET, BY APPLICATION 104
8.1 INTRODUCTION 105
8.2 CARDIOVASCULAR 107
8.2.1 CATHETERS 109
8.2.2 STENTS 109
8.2.3 IMPLANTABLE CARDIAC DEFIBRILLATORS 110
8.2.4 PACEMAKERS 111
8.2.5 SENSORS 112
8.2.6 HEART VALVES 112
8.2.7 VASCULAR GRAFTS 113
8.2.8 GUIDEWIRES 114
8.2.9 OTHERS 115
8.3 ORTHOPEDIC 116
8.3.1 JOINT REPLACEMENT 118
8.3.1.1 Knee Replacement 119
8.3.1.2 Hip Replacement 119
8.3.1.3 Shoulder Replacement 120
8.3.1.4 Others 121
8.3.2 VISCOSUPPLEMENTATION 122
8.3.3 BIORESORBABLE TISSUE FIXATION 124
8.3.3.1 Suture Anchors 125
8.3.3.2 Interference Screws 125
8.3.3.3 Meniscal Repair Tacks 126
8.3.3.4 Meshes 127
8.3.4 SPINE 127
8.3.4.1 Spinal Fusion 128
8.3.4.2 Minimally Invasive Fusion Surgeries 129
8.3.4.3 Motion Preservation & Dynamic Stabilization 130
8.3.4.3.1 Pedicle-based Rod Systems 131
8.3.4.3.2 Interspinous Spacers 131
8.3.4.3.3 Disc Arthroplasty/Replacement 132
8.3.5 FRACTURE FIXATION 133
8.3.5.1 Bone Plates 134
8.3.5.2 Screws 134
8.3.5.3 Pins 135
8.3.5.4 Rods 135
8.3.5.5 Wires 136
8.3.6 ORTHOBIOLOGICS 136
8.3.6.1 Synthetics Bone Grafts 136
?
8.4 OPHTHALMOLOGY 137
8.4.1 CONTACT LENSES 139
8.4.2 INTRAOCULAR LENSES 140
8.4.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUES 141
8.4.4 SYNTHETIC CORNEAS 142
8.4.5 OTHERS 143
8.5 DENTAL 144
8.5.1 DENTAL IMPLANTS 145
8.5.2 DENTAL BONE GRAFTS & SUBSTITUTES 146
8.5.3 DENTAL MEMBRANES 147
8.5.4 TISSUE REGENERATION 148
8.6 PLASTIC SURGERY 148
8.6.1 SOFT TISSUE FILLERS 150
8.6.2 CRANIOFACIAL SURGERY 151
8.7 WOUND HEALING 152
8.7.1 WOUND CLOSURE DEVICES 153
8.7.1.1 Sutures 154
8.7.1.2 Staples 155
8.7.2 SURGICAL HEMOSTATS 156
8.7.3 INTERNAL TISSUE SEALANTS 156
8.7.4 ADHESION BARRIERS 157
8.7.5 HERNIA MESHES 158
8.8 TISSUE ENGINEERING 158
8.8.1 SCAFFOLDS FOR REGENERATIVE MEDICINE 160
8.8.2 NANOMATERIALS FOR BIOSENSING 161
8.8.3 TAILORING OF INORGANIC NANOPARTICLES 162
8.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM 162
8.9.1 SHUNTING SYSTEMS 164
8.9.2 CORTICAL NEURAL PROSTHETICS (CNP) 165
8.9.3 HYDROGEL SCAFFOLDS FOR CNS REPAIR 166
8.9.4 NEURAL STEM CELL ENCAPSULATION 167
8.10 OTHER APPLICATIONS 168
8.10.1 DRUG DELIVERY SYSTEMS 170
8.10.2 GASTROINTESTINAL APPLICATIONS 171
8.10.3 BARIATRIC SURGERY 171
8.10.4 URINARY APPLICATIONS 173
?
9 GLOBAL BIOMATERIALS MARKET, BY REGION 174
9.1 INTRODUCTION 175
9.2 NORTH AMERICA 177
9.2.1 U.S. 179
9.2.1.1 Biomaterials-based Research in the U.S. 179
9.2.1.2 Growing Demand for Plastic Surgeries in the U.S. 180
9.2.1.3 Conferences and Symposiums on Biomaterials in the U.S. 181
9.2.1.4 Increase in Cancer Incidence 181
9.2.1.5 Growing Prevalence of Cardiovascular Diseases 181
9.2.2 CANADA 183
9.2.2.1 Increasing R&D Activities for Biomaterials in Canada 183
9.2.2.2 Growth in Geriatric Population in Canada 183
9.3 EUROPE 185
9.3.1 GERMANY 187
9.3.1.1 Rising Cases of Hip and Knee Replacements 187
9.3.1.2 Growing Medical Devices Industry in Germany 188
9.3.2 U.K. 189
9.3.2.1 Availability of Funds and Grants 189
9.3.2.2 Rise in CVD Prevalence in the U.K. 190
9.3.2.3 Conferences & Annual Meetings 190
9.3.2.4 Rising Volume of Cosmetic Surgeries in the U.K. 190
9.3.3 FRANCE 192
9.3.3.1 Favorable Government Support, Growth in Aging Population 192
9.3.4 SPAIN 193
9.3.4.1 Increasing Research Activities on Biomaterials 193
9.3.5 REST OF EUROPE (ROE) 194
9.3.5.1 Improving Healthcare Structure in Russia 194
9.3.5.2 RoE: Rising Geriatric Population 195
9.3.5.3 Turkey: Growth in the Healthcare Sector, Rising Medical Tourism 195
9.4 ASIA-PACIFIC 196
9.4.1 INTERNATIONAL ALLIANCES 196
9.4.2 JAPAN 199
9.4.2.1 Japan’s Growing Healthcare Industry 199
9.4.3 CHINA 200
9.4.3.1 Lucrative medical devices industry in China 200
9.4.3.2 China’s Favorable Tax Policy 200
9.4.3.3 Growing Aging Population 201
9.4.4 INDIA 202
9.4.4.1 India: A Hotspot for Cosmetic and Plastic Surgery 202
9.4.4.2 High Incidence of Cardiovascular Diseases 202
9.4.4.3 Increasing Geriatric Population 202
?
9.4.5 REST OF ASIA-PACIFIC (ROAPAC) 203
9.4.5.1 Rising Volume of Hip and Knee Replacement Procedures in Australia 203
9.4.5.2 Indonesia: Regulations Hindering Market Growth 204
9.4.5.3 Increasing Research in Australia, Singapore, and Hong Kong 204
9.5 REST OF THE WORLD (ROW) 205
9.5.1.1 Middle East: Increasing Geriatric Population, Rise in Age-related Disorders 205
9.5.1.2 High Prevalence of Obesity in Latin America 206
9.5.1.3 Opportunities in the Brazilian Market 206
9.5.1.4 Increasing Aging Population, Growing Cardiovascular Disease Prevalence in Brazil 206
9.5.1.5 Market Scenario in Latin America and South Africa 207
10 COMPETITIVE LANDSCAPE 209
10.1 OVERVIEW 209
10.2 COMPARATIVE ASSESSMENT OF KEY PLAYERS IN THE BIOMATERIALS MARKET (2013–2016) 209
10.3 COMPETITIVE SCENARIO 210
10.4 AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND JOINT VENTURES 211
10.4.1 PRODUCT LAUNCHES 212
10.4.2 MERGERS AND ACQUISITIONS 214
10.4.3 EXPANSIONS 215
10.4.4 OTHER STRATEGIES 216
11 COMPANY PROFILES 218
(Overview, Financial*, Products & Services, Strategy, and Developments)
11.1 INTRODUCTION 218
11.2 ROYAL DSM 219
11.3 BASF SE 227
11.4 CORBION N.V. 230
11.5 COVESTRO (SUBSIDIARY OF BAYER AG) 233
11.6 INVIBIO LTD. (SUBSIDIARY OF VICTREX PLC) 236
11.7 CARPENTER TECHNOLOGY CORPORATION 238
11.8 EVONIK INDUSTRIES AG 240
11.9 BERKELEY ADVANCED BIOMATERAILS, INC. 243
11.10 CAM BIOCERAMICS BV 244
11.11 CELANESE CORPORATION 245
*Details might not be captured in case of unlisted companies
?
12 APPENDIX 247
12.1 DISCUSSION GUIDE 247
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 260
12.4 AVAILABLE CUSTOMIZATION 260
12.5 RELATED REPORT 261
12.6 AUTHOR DETAILS 262

* indicates required information

* indicates required information


Share this Product


More from this collection